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Summary
Phenotypic bariability of vascular T o characterize the molecular changes of human aortic SMC during development and atherosclerosis, we have investigated the expression of three major adhesion-mediating proteins: vinculin/ metu-vinculin, VLA-1 integrin and fibronectin in fetal, child and adult human aortic SMC.
Results
The expression of smooth-muscle-specific variants of vinculin ( y-vinculin and metu-vinculin), VLA-1 integrin and both ED-A-and ED-H-containing variants of fibronectin, was studied by two-dimensional gel electrophoresis, quantitative immunoblotting and immunohistochemistry using specific antibodies to these molecules. The data obtained are summarized in Table 1 . Immunofluorescence analyses of 8-10-week-old fetuses have shown that mesenchymal cells surrounding the aorta expressed low levels of ED-A-, and ED-B-containing fibronectin, and were metu-vinculin, y-vinculin and VLA-1 integrin negative. In the same fetuses, aortic SMC expressed high levels of VLA-1 integrin, and both ED-A-and ED-R-containing fibronectin, but were metu-vinculin and y-vinculin negative. In 24-week-old fetal aorta, SMC contained very low levels of all the proteins studied. Analysis of SMC from child aorta indicated that during the post-natal period of human vascular smooth muscle development, the content of both VLA-1 integrin and smooth muscle-specific variants of vinculin increased, while in the 1.5-year-old aortic media the level of adhesion-mediating protein expression was the same as in fully differentiated adult SMC.
In the adult human aorta, SMCs occupy two anatomical layers: the tunica media and the tunica intima. The tunica intima is formed during postnatal growth starting from 10-12-year-old. The adult aortic intima can be divided into subendothelial and muscular-elastic (adjacent to media) sublayers. VLA-1 integrin, smooth muscle-specific vinculin variants and fibronectin were detected in the media and in both intimal sublayers. However, the content of adhesion-mediating proteins differed depending on the layer. Medial and intimal muscular-elastic SMC expressed high levels of VLA-1 integrin, y-vinculin and metu-vinculin, and both ED-A and ED-H-depleted fibronectin. In subendothelial intima, a ,-integrin subunit content, as well as y-vinculin and metu-vinculin contents, were significantly decreased compared with those in the adjacent muscular-elastic intima and media. In contrast to VLA-1 integrin and vinculin variants, the expression of ED-A-containing fibronectin dramatically increased in the subendothelial layer of both normal and atherosclerotic aortas.
Vascular SMC are known to undergo marked changes in phenotype when grown in cell culturemany of the characteristics typical of contractile SMC are lost even before the onset of active proliferation [ 11. T o determine whether the expression of y-vinculin, metu-vinculin, VLA-1 integrin and fibronectin was altered during the cultivation of SMC from human aortic media, we have estimated the content of smooth-muscle-specific variants of vinculin, a ,-chain of integrin and fibronectin variants in primary cultures of medial SMC by quantitative immunoblotting and immunofluorescence analysis. In the course of primary culture, the content of y-vinculin, metu-vinculin and the a ,-subunit of VLA-1 integrin dramatically decreased; at the same time, the proportion of ED-A-containing fibronectin gradually increased. Subcultured SMC expressed very low levels of smooth musclespecific variants of adhesion-mediating proteins, and did not differ from that of proliferating cells in primary culture. Different strategies for regulation of expression of individual gene products are used during smooth muscle development and phenotypic transitions of vascular SMC reflect variations of these strategies. In early development, activation of 'master' gene(s) analogous to MyoD probably determines commitment of the precursor cell to the smooth muscle lineage. Expression of such regulatory gene(s) itself does not immediately activate the expression of all cytodifferentiation markers, which include smooth muscle-specific variants of structural, contractile and adhesion-mediating proteins. These variants appear later during prenatal and post-natal periods [4] . Expression of cytodifferentiation markers is co-ordinately regulated during smooth muscle development [4] . W e were able to distinguish several phases of SMC phenotypic changes during human aorta development and atherogenesis. Our results reflect the existence of certain groups of cytodifferentiation markers whose expression might be regulated by different strategies. For instance, integrins, actin and myosin variants are encoded by genes belonging to the multigenic families; the selective co-ordinated expression of the smooth-muscle-specific members of these families is regulated at the transcriptional level by 'turning off non-muscle genes and 'turning on' smooth-muscle-specific ones. Another strategy for the selective expression of smooth-musclespecific proteins is via alternative splicing. In this case, tissue-specific trans-acting factors may be involved in the selection of the 'smooth-musclespecific' exons according to the cellular environment. The latter strategy seems to be very likely for such adhesion-mediating proteins as vinculin/ metuvinculin and fibronectin variants. Interestingly, the exon encoding the metu-vinculin-specific sequence, and both ED-A and ED-B encoding exons of fibronectin, are regulated independently during the development of aortic smooth muscle.
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Discussion
In conclusion, we have shown that ( a ) some adhesion-mediating proteins can serve as reliable markers of human aortic SMC development and differentiation; ( b ) human aortic SMC development proceeds through many stages in which SMC undergo phenotypic transitions; (c) in smooth muscle, certain groups of adhesion-mediating proteins exist whose expression during development might be controlled by two different basic mechanisms: those that select particular genes among other genes for expression in a particular development stage, and those that generate tissuespecific protein variants from a single gene via alternative pre-mRNA splicing. 
I075 Introduction
Cell-cell adhesion molecules (CAMs) have been implicated not only in intercellular recognition, but also in morphogenetic events, regeneration, tumour invasion and metastasis. CAMs have been identified by assays in vitro for cell binding. However, little is known about the biological function of these molecules. Some CAMs may primarily establish stable bonds between cells, whereas others may be expected to be involved in signalling between cells [l] . Rased on nucleic acid sequence data, the majority of known CAMs can be grouped into one of the following families: the integrin superfamily, the cadherin family, the immunoglobulin superfamily, the selectin family or the epidermal growth factor (EGF) family. CAMs bind either in a homophilic or a heterophilic manner. In homophilic binding the CAM species binds to itself, i.e. one CAM molecule on one cell binds to another identical CAM molecule on an opposing cell. In heterophilic binding the CAM molecule binds to a receptor molecule of different identity. Many CAMs are CaL+ dependent, e.g. the cadherins; other CAMs, such as the immunoglobulin superfamily members, are functionally independent of the presence of Ca'f ions. .
Abbreviations used: CAM. cell adhesion molecule; EGF, epidermal growth factor.
The integrin superfamily
The integrins are the primary mediators of cell-extracellular matrix adhesion. However, they also serve as one of the many families of molecules active in cell-cell adhesion [2-41. Integrins have been found to play a role in platelet aggregation, immune functions, tissue repair, tumour invasion and metastasis. Integrins are divided into subfamilies, each with a common /3-subunit capable of associating with a specific group of a-subunits. Recent work has shown that there are at least seven different P-subunits and eleven a-subunits. The aand P-subunits in various combinations form at least sixteen integrins. It is probable that more integrins remain to be discovered. Both a-and pchains are transmembrane proteins. The binding activity of many integrins is dependent on divalent cations. The extracellular domain of the a-subunit contains Ca'+-binding regions. Integrins react with cytoskeletal actin filaments via the linking proteins talin, vinculin and perhaps other cytoskeletal-associated molecules IS]. The cytoplasmic domain of the P-subunit seems to be especially important for integrin binding to cytoskeletal components. A tyrosine phosphorylation site has been demonstrated on the cytoplasmic part of the PI-and the P3-subunits indicating a possible regulatory mechanism of integrin function [ h ] . Many integrins bind to extracellular matrix proteins such as fibronectin, fibrin(ogen), laminin, various collagens, entactin, tenascin,
